|
Human Milk Oligosaccharides
Our Human Milk Oligosaccharides includes the range shown in Table 1
3'-Fucosyllactose | 41312-47-4 | C18H32O15 | 488.44 |
2’-Fucosyllactose | 41263-94-9 | C18H32O15 | 488.44 |
6'-Sialyllactose | 56144-12-8 | C23H39NO19 | 633.55 |
3'-Sialyllactose | 35890-38-1 | C23H39NO19 | 633.55 |
Lacto-N-tetraose | 14116-68-8 | C26H45NO21 | 707.63 |
Lacto-N-neotetraose | 13007-32-4 | C26H45NO21 | 707.63 |
Lacto-N-fucopentaose I | 7578-25-8 | C32H55NO25 | 853.77 |
Lacto-N-fucopentaose II | 21973-23-9 | C32H55NO25 | 853.77 |
Lacto-N-fucopentaose III | 25541-09-7 | C32H55NO25 | 853.77 |
Lacto-N-fucopentaose V | 60254-64-0 | C32H55NO25 | 853.77 |
上海惠诚生物科技有限公司 “惠质产品,挚诚服务”。
特色产品:糖类标准品,脂肪酸标准品,花青素标准品,类胡萝卜素等食品分析标准品
联系人吕海秀,021-60498804,13917250134。
中性人乳寡糖(Neutral human milk oligosaccharides)
产品编号
|
产品名称
|
产品描述
|
---|---|---|
GLY031-3 |
2'-岩藻糖基乳糖 2’-FL/2’Fucosyllactose
Fucα1-2Galβ1-4Glc
|
Blood group (O) H triaose antigen type 5
C18H32O15 FW 488.43 CAS [41263-94-9] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
3-岩藻糖基乳糖 3-FL/3Fucosyllactose
Galβ1-4(Fucα1-3)Glc
|
C18H32O15
FW 488.43 CAS [41312-47-4] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-二岩藻四糖 Difucosyllactose/DF-L
Fucα1-2Galβ1-4(Fucα1-3)Glc
|
Lactodifucotetraose (LD)
C24H42O19 FW 634.57 CAS [20768-11-0] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-四糖 LNT/Lacto-N-tetraose
Galβ1-3GlcNAcβ1-3Galβ1-4Glc
|
Core structure type 1
C26H45NO21 FW 707.62 CAS [14116-68-8] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-新四糖 LNnT/ neo-LNT / Lacto-N-neotetraose
Galβ1-4GlcNAcβ1-3Galβ1-4Glc
|
Core structure type 2
C26H45NO21 FW 707.62 CAS [13007-32-4] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-岩藻五糖I, LNFP I / Lacto-N-fucopentaose I
Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4Glc
|
H血型抗原五糖,1型
Blood group O (H) antigen pentaose type 1 C32H55NO25 FW 853.76 CAS [7578-25-8] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-二岩藻糖基-六糖II; LNDFH II / Lacto-N-difucohexaose II
Galβ1-3(Fucα1-4)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc
|
Lewisa(Lea) 抗原六糖
Lewisa(Lea) hexaose C38H65NO29 FW 999.90 CAS [62258-12-2] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-二岩藻糖基-六糖III LNnDFH / Lacto-N-neodifucohexaose
Galβ1-4(Fucα1-3)GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc
|
LewisX(LeX) 抗原六糖
LewisX(LeX) hexaose/LNDFH III C38H65NO29 FW 999.90 Reference: Perret S et al., 2005 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
对-乳糖-N-新六糖 Para-LNnH / Para-Lacto-N-neohexaose
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glc
|
C40H68N2O31
FW 1072.96 CAS [64331-48-2] Reference: BoehmG et al. 2003 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-新八糖 LNnO/Lacto-N-neooctaose
Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4GlcNAcβ1- 3Galβ1-4Glc
|
C54H91N3O41
FW 1438.29 Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-岩藻五糖 LNFP V / Lacto-N-fucopentaose V
Galβ1-3GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc
|
C32H55NO25
FW 853.76 CAS [60254-64-0] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
乳糖-N-新岩藻五糖 LNnFP V / Lacto-N-neofucopentaose V
Galβ1-4GlcNAcβ1-3Galβ1-4(Fucα1-3)Glc
|
C32H55NO25
FW 853.76 Reference: Perret S et al., 2005 5 mg, 25 mg, 100 mg, 1 g, 5 g |
产品编号
|
产品名称
|
产品描述
|
---|---|---|
3'-唾液酸基-3-岩藻糖基乳糖 3’Sialyl-3Fucosyllactose/ F-SL (sodium salt)
Neu5Acα2-3Galβ1-4(Fucα1-3)Glc
|
C29H48NO23Na
FW 801.67 Reference: Boehm G et al. 2003 5 mg, 25 mg, 100 mg, 1 g, 5 g |
|
3'-唾液酸基-乳糖 3’-SL / 3'Sialyllactose(sodium salt)
Neu5Acα2-3Galβ1-4Glc
|
GM3神经节苷脂糖
GM3 ganglioside oligosaccharide C23H38NO19Na FW 655.53 CAS [35890-38-1] Reference: Kunz C et al. 2000 100 mg, 1 g, 5 g |
|
|
LS-四糖 a (LSTa) / 唾液酸-乳糖-N-四糖 a
LSTa / LS-Tetrasaccharide a / Sialyllacto-N-tetraose a(sodium salt)
Neu5Acα2-3Galβ1-3GlcNAcβ1-3Galβ1-4Glc
|
C37H61N2O29Na
FW 1020.86 CAS [64003-58-5] Reference: Kunz C et al. 2000 5 mg, 25 mg, 100 mg, 1 g, 5 g
人乳寡糖(HMOs)可分为中性人乳寡糖(Neutral human milk oligosaccharides)和酸性人乳寡糖(Acidic human milk oligosaccharides)。中性人乳寡糖是包含岩藻糖基的低聚糖,酸性人乳寡糖是包含唾液酸及其硫酸盐的结构的低聚糖。人乳中中性人乳寡糖大约占70%,酸性人乳寡糖大约占30%。指纹图谱中)
|